bromhexine has been researched along with Benign Neoplasms in 1 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donoghue, V | 1 |
| Ryan, S | 1 |
| Twomey, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| European Low and Intermediate Risk Neuroblastoma Protocol[NCT01728155] | Phase 3 | 685 participants (Actual) | Interventional | 2011-01-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bromhexine and Benign Neoplasms
| Article | Year |
|---|---|
Perinatal tumours: the contribution of radiology to management.
Topics: Bromhexine; Humans; Infant, Newborn; Magnetic Resonance Imaging; Neoplasms | 2008 |